Welcure Drugs and Pharmaceuticals Limited (BOM:524661)
India flag India · Delayed Price · Currency is INR
0.3700
-0.0100 (-2.63%)
At close: Jan 20, 2026

BOM:524661 Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Sep '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2016 - 2020
Net Income
324.8121.7-1.751.020.240.55
Upgrade
Depreciation & Amortization
0.090.080.36---
Upgrade
Other Operating Activities
113.066.1-00--
Upgrade
Change in Accounts Receivable
-3,513-189.5----
Upgrade
Change in Inventory
0-1,435----
Upgrade
Change in Accounts Payable
1,67928.98----
Upgrade
Change in Other Net Operating Assets
162.65-652.410.110.05-0.05-0.13
Upgrade
Operating Cash Flow
-1,233-2,220-1.281.070.190.42
Upgrade
Operating Cash Flow Growth
---476.20%-56.02%-
Upgrade
Capital Expenditures
--0.17----
Upgrade
Investment in Securities
--1.65---
Upgrade
Other Investing Activities
0.12-0.47----
Upgrade
Investing Cash Flow
0.12-0.641.65---
Upgrade
Long-Term Debt Issued
-1,232----
Upgrade
Long-Term Debt Repaid
---0.17-14.92--
Upgrade
Net Debt Issued (Repaid)
1,2321,232-0.17-14.92--
Upgrade
Issuance of Common Stock
-990-13.21--
Upgrade
Financing Cash Flow
1,2322,222-0.17-1.72--
Upgrade
Miscellaneous Cash Flow Adjustments
000---
Upgrade
Net Cash Flow
-1.031.070.2-0.650.190.42
Upgrade
Free Cash Flow
-1,233-2,220-1.281.070.190.42
Upgrade
Free Cash Flow Growth
---476.20%-56.02%-
Upgrade
Free Cash Flow Margin
-33.73%-904.46%--17.67%31.64%
Upgrade
Free Cash Flow Per Share
-1.46-2.59-0.010.010.000.00
Upgrade
Levered Free Cash Flow
-449.82-1,3901.010.310.150.47
Upgrade
Unlevered Free Cash Flow
-449.82-1,3901.010.310.150.47
Upgrade
Change in Working Capital
-1,671-2,2480.110.05-0.05-0.13
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.